Enlivex (ENLV) has released an update.
Enlivex Therapeutics has announced a strategic decision to invest up to $1 million in Bitcoin as part of its cash management strategy. The company believes Bitcoin’s growing acceptance and institutional support make it a strong treasury reserve asset and a potential hedge against inflation. This move reflects a broader trend among companies seeking diversification in their financial reserves.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.